Home > Insider Trading > Filing (0001140361-10-012628)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1441848	Facet Biotech Corp	FACT	Pharmaceutical Preparations (2834)	263070657

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
899869	A Seth Klarman	10 St. James Ave Suite 1700 Boston MA 02116	No	No	Yes	No
1061088	Sak Corp	10 St James Ave Suite 1700 Boston MA 02116	No	No	Yes	No
1061768	Baupost Group Llc/Ma	10 St James Ave Suite 1700 Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value Per Share	Disposition	2010-03-16	1,506,875	$27.00	2,000,000	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. (?Baupost?), SAK Corporation and Seth A. Klarman. Baupost is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment limited partnerships. Securities reported on this Form 4 as being beneficially owned by Baupost include securities held by such investment limited partnerships, for which Baupost is the general partner and investment adviser. SAK Corporation is the manager of Baupost. Mr. Klarman is the sole director and sole officer of SAK Corporation and a controlling person of Baupost. The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interests therein.